Drugs / Z-100
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00016692 | — | HIV infectious disease | Zeria Pharmaceutical | Terminated | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT03476018 | Apr 2018 → Jul 2021 | cervical cancer | Zeria Pharmaceutical | Completed | No outcome recorded |
| Phase 3 | NCT02247232 | Dec 2014 → Jun 2021 | cervical cancer | Zeria Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Z-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02247232 ↗ |